Kintor Pharma announces first patient dosing of phase-III clinical trial of Pyrilutamide to treat…
On 24th November, 2021, Kintor Pharma announced that China's National Medical Products Administration (NMPA) greenlighted the…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.